These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32779129)

  • 1. Considerations in the Assessment of Clinical Benefit with a Focus on Pain: a Regulatory Perspective.
    St Clair CO; Papadopoulos EJ
    Neurotherapeutics; 2020 Jul; 17(3):770-773. PubMed ID: 32779129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.
    Taylor AM; Phillips K; Patel KV; Turk DC; Dworkin RH; Beaton D; Clauw DJ; Gignac MAM; Markman JD; Williams DA; Bujanover S; Burke LB; Carr DB; Choy EH; Conaghan PG; Cowan P; Farrar JT; Freeman R; Gewandter J; Gilron I; Goli V; Gover TD; Haddox JD; Kerns RD; Kopecky EA; Lee DA; Malamut R; Mease P; Rappaport BA; Simon LS; Singh JA; Smith SM; Strand V; Tugwell P; Vanhove GF; Veasley C; Walco GA; Wasan AD; Witter J
    Pain; 2016 Sep; 157(9):1836-1850. PubMed ID: 27058676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.
    Basch E; Trentacosti AM; Burke LB; Kwitkowski V; Kane RC; Autio KA; Papadopoulos E; Stansbury JP; Kluetz PG; Smith H; Justice R; Pazdur R
    Cancer; 2014 Mar; 120(5):761-7. PubMed ID: 24375398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION.
    Dworkin RH; Turk DC; Katz NP; Rowbotham MC; Peirce-Sandner S; Cerny I; Clingman CS; Eloff BC; Farrar JT; Kamp C; McDermott MP; Rappaport BA; Sanhai WR
    Pain; 2011 Mar; 152(3 Suppl):S107-S115. PubMed ID: 21145657
    [No Abstract]   [Full Text] [Related]  

  • 7. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.
    Turk DC; Dworkin RH; Allen RR; Bellamy N; Brandenburg N; Carr DB; Cleeland C; Dionne R; Farrar JT; Galer BS; Hewitt DJ; Jadad AR; Katz NP; Kramer LD; Manning DC; McCormick CG; McDermott MP; McGrath P; Quessy S; Rappaport BA; Robinson JP; Royal MA; Simon L; Stauffer JW; Stein W; Tollett J; Witter J
    Pain; 2003 Dec; 106(3):337-345. PubMed ID: 14659516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing tumor-related signs and symptoms to support cancer drug approval.
    Williams G; Pazdur R; Temple R
    J Biopharm Stat; 2004 Feb; 14(1):5-21. PubMed ID: 15027497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concerns.
    Sridhara R; Chen G; Chi GY; Griebel DJ
    J Biopharm Stat; 2004 Feb; 14(1):23-30. PubMed ID: 15027498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cut-points for the measurement of pain: the choice depends on what you want to study.
    Farrar JT
    Pain; 2010 May; 149(2):163-164. PubMed ID: 20347224
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
    Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
    Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology.
    Rowe-Rendleman CL
    Pharm Res; 2019 Feb; 36(4):54. PubMed ID: 30790065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated approval of oncology products: the food and drug administration experience.
    Johnson JR; Ning YM; Farrell A; Justice R; Keegan P; Pazdur R
    J Natl Cancer Inst; 2011 Apr; 103(8):636-44. PubMed ID: 21422403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do you expect from this treatment? Changing our mind about clinical trials.
    Benedetti F
    Pain; 2007 Apr; 128(3):193-194. PubMed ID: 17292547
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized controlled trial of tai chi for long-term low back pain (TAI CHI): study rationale, design, and methods.
    Hall AM; Maher CG; Latimer J; Ferreira ML; Lam P
    BMC Musculoskelet Disord; 2009 May; 10():55. PubMed ID: 19473546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
    Liu Q; Chi GY
    J Biopharm Stat; 2010 Nov; 20(6):1178-219. PubMed ID: 21058114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.
    Turk DC; Dworkin RH; Revicki D; Harding G; Burke LB; Cella D; Cleeland CS; Cowan P; Farrar JT; Hertz S; Max MB; Rappaport BA
    Pain; 2008 Jul; 137(2):276-285. PubMed ID: 17937976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.